SOARD Category 1 CME Credit Featur
ed Articles, Volume 9, March–April 2013Restoration of glycemic control in patients with type 2 diabetes after bariatric surgery isassociated with reduction in microparticles.Cheng V, Kashyap SR, Schauer PR, Kirwan JP, McCrae KR.
Surg Obes Relat Dis 2013;9;207–12.
Risk factors for acute respiratory failure in bariatric surgery: data from the NationwideInpatient Sample, 2006–2008.Masoomi H, Reavis KM, Smith BR, Kim H, Stamos MJ, Nguyen NT.
Surg Obes Relat Dis 2013;9;277–81.
Objectives: After reading the featured articles published inthis issue of Surgery for Obesity and Related Diseases(SOARD) participants in the SOARD CME programshould be able to demonstrate increased understanding ofthe material specific to the article featured and be able toapply relevant information to clinical practice. Objectivesare stated at the beginning of each featured article; thequestions follow with three to five response choices, and acritique discussing the objective.Disclosure Statement: It is the policy of the AmericanSociety for Metabolic and Bariatric Surgery that speakersand/or anyone in control of content of a CME Category 1event must disclose any financial or other relationship with(1) any manufacturer(s) of commercial products that maybe discussed in the speaker’s presentation and/or (2)commercial supporters of the event.Accreditation Statement: The American Society forMetabolic and Bariatric Surgery (ASMBS) is accreditedby the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medicaleducation for physicians. The American Society forMetabolic and Bariatric Surgery (ASMBS) designates thiseducational activity for a maximum of 2 AMA PRACategory 1 Credits. Physicians should only claim creditcommensurate with the extent of their participation in theactivity. SOARD CME Online provides two articles fromeach issue for 2 credits per month; 1 credit per article. Thearticles this month on SOARD CME Online are:1550-7289/13/$ – see front matter r 2013 Published by Elsevier Inc. on behalfhttp://dx.doi.org/10.1016/j.soard.2013.02.006
Restoration of glycemic control in patients with type 2diabetes after bariatric surgery is associated withreduction in microparticles
Cheng V, Kashyap SR, Schauer PR, Kirwan JP, McCrae KR.
Surg Obes Relat Dis 2013;9;207–12.
Disclosures
Dr. Schauer’s disclosures include Ethicon Endo-Surgery, con-sultant, scientific advisory board member, research support;Remedy MD, board of directors; Stryker Endoscopy, scientificadvisory board, educational grant; Bard/Davol, scientificadvisory board, consultant; Gore, consultant, educationalgrant; Baxter, educational grant; Barosense, Surgiquest, andCardinal/Snowden Pencer, scientific advisory board; Covidien,educational grant; Allergan, educational grant; Surgical Excel-lence LLC, board of directors. Dr. Kashyap’s disclosuresinclude Ethicon Endo-Surgery, consultant, research support.Dr. Kirwan’s disclosures include Bristol Myers Squibb, scien-tific advisory board; AstraZeneca, scientific advisory board;Nestle Int., research support. Drs. Cheng and McCrae have noconflicts of interest or financial ties to disclose.
Risk factors for acute respiratory failure in bariatricsurgery: data from the Nationwide Inpatient Sample,2006–2008
Masoomi H, Reavis KM, Smith BR, Kim H, Stamos MJ,Nguyen NT.
Surg Obes Relat Dis 2013;9;277–81.
of American Society for Metabolic and Bariatric Surgery.
Continuing Medical Education Program / Surgery for Obesity and Related Diseases 9 (2013) 331–333 333
ARTICLE 1
Restoration of glycemic control in patients with
ARTICLE 2
Risk factors for acute respiratory failure in bariatric
type 2 diabetes after bariatric surgery is associatedwith reduction in microparticlesCheng V, Kashyap SR, Schauer PR, Kirwan JP, McCrae KR.
Surg Obes Relat Dis 2013;9;207–12.
Learning Objectives
This article presents data on cellular microparticle con-centrations that are associated with cardiovascular risk andits association to metabolic benefits conferred by bariatricsurgery in obesity and type 2 diabetes.
Question 1
Cardiovascular risk related to morbid obesity is conferred bythe following cytokines EXCEPT:
A. C
-reactive protein levels B. T NFa C. G lucagon like peptide (GLP-1) D. A diponectin E. G hrelin levelsQuestion 2
Which of the following metabolic syndrome parameters confersthe least cardiovascular risk in patient with Type 2 diabetes:
A. H
ypertention B. A bdominal adiposity C. H yperlipidemia D. H yperglycemiaQuestion 3
Which of the following statements is true regardingmicroparticle concentrations in type 2 diabetes:
A. I
ncreased endothelial, platelet and monocyte micro-particles have been documented in diabeticpatients with retinopathy and microvascular com-plicationsB. I
ncreased platelet microparticles have been documentedin diabetic patients with peripheral vascular diseaseC. I
ncreased monocyte microparticles have been linked tothrombotic events in patients with diabetesD. I
ncreased microparticles concentrations predict cancerrisk in patients with diabetessurgery: data from the Nationwide InpatientSample, 2006–2008
Masoomi H, Reavis KM, Smith BR, Kim H, Stamos MJ,Nguyen NT.
Surg Obes Relat Dis 2013;9;277–81.
Learning Objectives
1.
Understand factors associated with acute respiratoryfailure (ARF) in bariatric surgery.2.
Understand the frequency of acute respiratory failureafter bariatric surgery.3.
Understand outcomes of patients with vs. without ARF.Question 1
Acute respiratory failure (ARF) rate in bariatric surgery is:
A. L
ower after laparoscopic compared to open bariatricsurgeryB. H
igher after non-gastric bypass compared to gastricbypass operationsC. M
ore than 10%Question 2
Which factor has not been shown to be associated withARF?
A. O
pen technique B. C ongestive heart failure C. F emale sex D. C hronic renal failureQuestion 3
Compared to patients without ARF, patients with ARFhave:
A. L
onger hospital stay B. L ower hospital charges C. L ower in-hospital mortality D. L ower mean ageQuestion 4
The highest rate of ARF was observed after:
A. L
aparoscopic gastric bypass B. L aparoscopic gastroplasty C. O pen gastric bypass D. L aparoscopic gastric banding